Leon-Triana2020 - CAR T-cell therapy in B-cell acute lymphoblastic leukaemia with contribution from immature B cells Lab
About lab
This model is based on the publication:'CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models'.Odelaisy León-Triana, Soukaina Sabir, Gabriel F. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packageleon-triana2020-car-t-cell-therapy-in-b-cell-acute-lymphoblastic
Created2026-05-15
Updated2026-05-15
immunologysbmlbiomodels_ebifaithfulcuratedvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "initial_car_t_cells",
"label": "Initial Car T Cells",
"units": "native source value",
"default": 10000000,
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.initial_car_t_cells",
"description": "Initial Car T Cells. Sets the initial value of bundled SBML species `CAR_T_cells`."
},
{
"name": "initial_leukaemic_b_cells",
"label": "Initial Leukaemic B Cells",
"units": "native source value",
"default": 50000000000,
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.initial_leukaemic_b_cells",
"description": "Initial Leukaemic B Cells. Sets the initial value of bundled SBML species `Leukaemic_B_cells`."
},
{
"name": "initial_cells_healthy",
"label": "Initial Cells Healthy",
"units": "native source value",
"default": 25000000000,
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.initial_cells_healthy",
"description": "Initial Cells Healthy. Sets the initial value of bundled SBML species `B_cells_healthy`."
},
{
"name": "initial_cell_progenitors",
"label": "Initial Cell Progenitors",
"units": "native source value",
"default": 10000000,
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.initial_cell_progenitors",
"description": "Initial Cell Progenitors. Sets the initial value of bundled SBML species `B_cell_progenitors`."
},
{
"name": "cartcell_proliferation_rate",
"label": "Cartcell Proliferation Rate",
"units": "native source value",
"default": 0.1,
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.cartcell_proliferation_rate",
"description": "Cartcell Proliferation Rate. Sets bundled SBML parameter `beta`."
}
],
"outputs": [
{
"name": "car_t_cells",
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.car_t_cells"
},
{
"name": "leukaemic_b_cells",
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.leukaemic_b_cells"
},
{
"name": "cells_healthy",
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.cells_healthy"
},
{
"name": "cell_progenitors",
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.cell_progenitors"
},
{
"name": "state",
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.state"
},
{
"name": "summary",
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.summary"
},
{
"name": "species_labels",
"maps_to": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.species_labels"
}
]
},
"title": "Leon-Triana2020 - CAR T-cell therapy in B-cell acute lymphoblastic leukaemia with contribution from immature B cells Lab",
"models": [
{
"path": "owned/models/immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model",
"alias": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model",
"provenance": {
"owned_path": "owned/models/immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model_state"
],
"from": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.state"
},
{
"to": [
"visualisation.immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model_summary"
],
"from": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.summary"
},
{
"to": [
"visualisation.immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model_species_labels"
],
"from": "immunology_sbml_leon_triana2020_car_t_cell_therapy_in_b_cell_acu_biomd0000001012_model.species_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "This model is based on the publication:'CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models'.Odelaisy León-Triana, Soukaina Sabir, Gabriel F. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.